Cargando…

Lenvatinib-induced multiorgan adverse events in Hurthle cell thyroid cancer: A case report

BACKGROUND: The management of metastatic progressive radioiodine-resistant differentiated thyroid cancer remains challenging for clinicians. The availability of tyrosine kinase inhibitors (TKIs), sorafenib and lenvatinib, within the last decade has expanded treatment options; however, these lead to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Butt, Muhammad Imran, Khalid Bakhsh, Abdulmohsen Mohammed, Nadri, Quaid Johar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8085512/ https://www.ncbi.nlm.nih.gov/pubmed/33959480 http://dx.doi.org/10.5306/wjco.v12.i4.272

Ejemplares similares

Lenvatinib as a Promising Treatment Option for Unresectable Hürthle Cell Carcinoma: A Case Report
por: Shirode, Parth S, et al.
Publicado: (2023)

Thyroid FNAC containing hürthle cells and hürthle-like cells: A study of 128 cases
por: Yazgan, Aylin, et al.
Publicado: (2016)

Cortisol Deficiency in Lenvatinib Treatment of Thyroid Cancer: An Underestimated Common Adverse Event
por: Monti, Salvatore, et al.
Publicado: (2022)

SUN-615 Hurdles in Hurthle Cell Cancer: A Case Report on Hurthle Cell Thyroid Cancer with Vertebral Metastasis
por: Viar, John Ryan, et al.
Publicado: (2019)

Core I gene is overexpressed in Hürthle and non-Hürthle cell microfollicular adenomas and follicular carcinomas of the thyroid
por: Máximo, Valdemar, et al.
Publicado: (2004)

Relationship between adverse events associated with lenvatinib treatment for thyroid cancer and patient prognosis
por: Iwasaki, Hiroyuki, et al.
Publicado: (2021)

Functional polymorphisms in antioxidant genes in Hurthle cell thyroid neoplasm - an association of GPX1 polymorphism and recurrent Hurthle cell thyroid carcinoma
por: Krhin, Blaz, et al.
Publicado: (2016)

Issues in Managing Hurthle Cell Carcinoma of Thyroid: A Case Report
por: Tai, Patricia, et al.
Publicado: (2017)

Thyroid hemiagenesis associated with Hurthle cell carcinoma: A case report
por: Kartini, Diani, et al.
Publicado: (2021)

Genetics, Diagnosis, and Management of Hürthle Cell Thyroid Neoplasms
por: McFadden, David G., et al.
Publicado: (2021)

Diagnostic performance of thyroid ultrasound in Hürthle cell carcinomas
por: Santana, Nathalie Oliveira, et al.
Publicado: (2019)

Appearance of Hürthle cell carcinoma soon after surgical extirpation of Hürthle cell adenoma and follicular adenoma of the thyroid gland
por: Ristevska, Nevena, et al.
Publicado: (2015)

Expression of somatostatin receptors in oncocytic (Hürthle cell) neoplasia of the thyroid
por: Tisell, L E, et al.
Publicado: (1999)

Thyroid Hürthle Cell Carcinoma: Clinical, Pathological, and Molecular Features
por: Kure, Shoko, et al.
Publicado: (2020)

Hürthle cell neoplasms of the thyroid: Pathologic outcomes and ultrasonographic analysis
por: Shin, Timothy J., et al.
Publicado: (2020)

Hurthle cell carcinoma: a rare variant of thyroid malignancy – a case report
por: Adhikari, Yuvraj, et al.
Publicado: (2023)

Concurrence of Papillary Thyroid Carcinoma and Hürthle Cell Carcinoma in an Iranian Woman with Hashimoto's Thyroiditis
por: Samiee-Rad, Fatemeh, et al.
Publicado: (2019)

ODP469 Coexistence of two thyroid malignancies with Hurthle cell and Papillary thyroid carcinoma
por: Hamouche, Walid, et al.
Publicado: (2022)

Multiple Hürthle cell adenomas in a patient with thyroid hormone resistance
por: Xifra, Gemma, et al.
Publicado: (2013)

Defective ciliogenesis in thyroid hürthle cell tumors is associated with increased autophagy
por: Lee, Junguee, et al.
Publicado: (2016)

Thyroid Nodule Size as a Predictor of Malignancy in Follicular and Hurthle Neoplasms
por: Boonrod, Arunnit, et al.
Publicado: (2021)

Guillian-Barre syndrome as the initial presentation of systemic lupus erythematosus – case report and review of literature
por: Nadri, Quaid, et al.
Publicado: (2015)

Metastatic Hurthle Cell Carcinoma of the thyroid presenting as a Breast Lump: A Case Report
por: Al-Abed, Yahya, et al.
Publicado: (2008)

Typical manifestations of Hürthle cell adenoma of the thyroid on contrast-enhanced CT: A case report
por: Deng, Dayong, et al.
Publicado: (2019)

Graves disease and metastatic hormonal-active Hürthle cell thyroid cancer: A case report
por: Besic, Nikola, et al.
Publicado: (2021)

Isolated Liver Metastasis in Hürthle Cell Thyroid Cancer Treated with Microwave Ablation
por: Segkos, Konstantinos, et al.
Publicado: (2017)

Thyroid nodules with Hürthle cells: the malignancy risk in relation to the FNA outcome category
por: Słowińska-Klencka, D., et al.
Publicado: (2019)

Usability of EU-TIRADS in the Diagnostics of Hürthle Cell Thyroid Nodules with Equivocal Cytology
por: Słowińska-Klencka, Dorota, et al.
Publicado: (2020)

Cytological and molecular diagnosis of Hürthle cell thyroid tumors: Analysis of three cases
por: Titov, Sergei E., et al.
Publicado: (2021)

Lenvatinib for Anaplastic Thyroid Cancer
por: Tahara, Makoto, et al.
Publicado: (2017)

Expert consensus on the management of adverse events in patients receiving lenvatinib for hepatocellular carcinoma
por: Kim, Bo Hyun, et al.
Publicado: (2021)

Neoadjuvant lenvatinib for inoperable thyroid cancer: A case report and literature review
por: Alshehri, Khalid, et al.
Publicado: (2021)

Thyroid Storm with Multiorgan Failure Treated with Plasmapheresis
por: Miller, Ann, et al.
Publicado: (2019)

Fine-Needle Aspiration Cytology of Parathyroid Carcinoma Mimic Hürthle Cell Thyroid Neoplasm
por: Sriphrapradang, Chutintorn, et al.
Publicado: (2014)

A Rare Silent Killer: Right Atrial Metastasis of Thyroid Hürthle Cell Carcinoma
por: Luo, Hongxiu, et al.
Publicado: (2015)

Hürthle cell carcinoma: current perspectives
por: Ahmadi, Sara, et al.
Publicado: (2016)

Challenges in Cytology Specimens With Hürthle Cells
por: Thodou, Eleni, et al.
Publicado: (2021)

Point mutation in GRIM-19: a new genetic lesion in Hurthle cell thyroid carcinomas
por: Fusco, A, et al.
Publicado: (2005)

Recurrent Hurthle cell thyroid carcinoma does not preclude long-term survival: a case report and review of the literature
por: Blossey, Richard David, et al.
Publicado: (2021)

Posterior Reversible Encephalopathy Syndrome as an Adverse Effect of Lenvatinib in a Patient with Papillary Thyroid Carcinoma: A Case Report
por: Buenaventura, Daisy Carolina, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_id06v00o28kpf3pr3qs3kd5vb6